Sanchez Otto A, Jacobs David R, Bahrami Hossein, Peralta Carmen A, Daniels Lori B, Lima João A, Maisel Alan, Duprez Daniel A
aSchool of Public Health, Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, Minnesota bStanford University, Stanford cSchool of Medicine, University of California, San Francisco dDivision of Cardiology, University of California, San Diego, California eDivision of Cardiology, Johns Hopkins Bayview Medical Center, Baltimore, Maryland fSchool of Medicine, University of California, San Diego, California gDivision of Cardiology, University of Minnesota, Minneapolis, Minnesota, USA.
J Hypertens. 2015 May;33(5):966-74. doi: 10.1097/HJH.0000000000000500.
Longitudinal associations between the aminoterminal pro-B-type natriuretic peptide (NT-proBNP) and incident hypertension are lacking.
We tested associations between baseline NT-proBNP (bNT-proBNP) and change in NT-proBNP (ΔNT-proBNP) (visit 3 NT-proBNP - bNT-proBNP, 3.2 years apart) with incident hypertension (SBP ≥ 140 and/or DBP ≥90 mmHg or taking antihypertensive medications). Incident hypertension was evaluated in 5596 individuals in the Multi-Ethnic Study of Atherosclerosis without hypertension at baseline (53% women, age range 45-84 years without overt cardiovascular disease) and follow-up for 9.5 years and in a subgroup (1550) who had bNT-proBNP less than 100 pg/ml and no hypertension at visit 3. Incident hypertension was regressed (proportional hazards) on quintiles of bNT-proBNP (range) (reference <19.2, 19.3-40.8, 40.9-70.9, 71-135.2, and >135.5) and also on ΔNT-proBNP categories (reference <-10, -10 to 10, >10 to 50, and >50 pg/ml). Hazard ratios were adjusted for age, race, sex, education, diabetes, obesity, left ventricle mass/height, SBP and DBP, interleukin-6, salt intake, estimated glomerular filtration rate, and exercise.
Compared with the reference category, hazard ratios (95% confidence interval) for incident hypertension compared with the first quintile of bNT-proBNP were 1.47 (1.13-1.93), 1.57 (1.18-2.09), 1.52 (1.12-2.06), and 2.36 (1.62-3.41). Hazard ratios for incident hypertension by categories of ΔNT-proBNP from 3.2 to 9.5 years follow-up were 0.98 (0.62-1.56), 1.13 (0.72-1.79), and 1.82 (1.07-3.12).
The development of hypertension tended to be preceded by elevated levels of bNT-proBNP or a substantial positive ΔNT-proBNP.
氨基末端前B型利钠肽(NT-proBNP)与高血压发病之间的纵向关联尚不清楚。
我们测试了基线NT-proBNP(bNT-proBNP)和NT-proBNP的变化(ΔNT-proBNP)(访视3时的NT-proBNP - bNT-proBNP,间隔3.2年)与高血压发病(收缩压≥140和/或舒张压≥90 mmHg或服用抗高血压药物)之间的关联。在动脉粥样硬化多民族研究中的5596名基线时无高血压的个体(53%为女性,年龄范围45 - 84岁,无明显心血管疾病)中评估高血压发病情况,并随访9.5年;在一个亚组(1550名)中进行评估,这些个体在访视3时bNT-proBNP低于100 pg/ml且无高血压。将高血压发病情况(比例风险)与bNT-proBNP五分位数(范围)(参考值<19.2、19.3 - 40.8、40.9 - 70.9、71 - 135.2和>135.5)以及ΔNT-proBNP类别(参考值<-10、-10至10、>10至50和>50 pg/ml)进行回归分析。风险比针对年龄、种族、性别、教育程度、糖尿病、肥胖、左心室质量/身高、收缩压和舒张压、白细胞介素-6盐摄入量、估计肾小球滤过率和运动进行了调整。
与参考类别相比,与bNT-proBNP第一五分位数相比,高血压发病的风险比(95%置信区间)分别为1.47(1.13 - 1.93)、1.57(1.18 - 2.09)、1.52(1.12 - 2.06)和2.36(1.62 - 3.41)。在3.2至9.5年随访期间,按ΔNT-proBNP类别划分的高血压发病风险比分别为0.98(0.62 - 1.56)、1.13(0.72 - 1.79)和1.82(1.07 - 3.12)。
高血压的发生往往在bNT-proBNP水平升高或ΔNT-proBNP显著升高之前。